These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2339 related articles for article (PubMed ID: 16334758)

  • 1. Metastatic potential in T1 and T2 colorectal cancer.
    Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can depth of tumour invasion predict lymph node positivity in patients undergoing resection for early rectal cancer? A comparative study between T1 and T2 cancers.
    Rasheed S; Bowley DM; Aziz O; Tekkis PP; Sadat AE; Guenther T; Boello ML; McDonald PJ; Talbot IC; Northover JM
    Colorectal Dis; 2008 Mar; 10(3):231-8. PubMed ID: 18257848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
    Lotan Y; Gupta A; Shariat SF; Palapattu GS; Vazina A; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Perotte P; Schoenberg MP; Lerner SP; Sagalowsky AI
    J Clin Oncol; 2005 Sep; 23(27):6533-9. PubMed ID: 16116151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of lymph node metastasis in T1 colorectal carcinoma.
    Yamamoto S; Watanabe M; Hasegawa H; Baba H; Yoshinare K; Shiraishi J; Kitajima M
    Hepatogastroenterology; 2004; 51(58):998-1000. PubMed ID: 15239233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of lymphovascular invasion in sporadic colorectal cancer.
    Lim SB; Yu CS; Jang SJ; Kim TW; Kim JH; Kim JC
    Dis Colon Rectum; 2010 Apr; 53(4):377-84. PubMed ID: 20305435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosis.
    Wang HS; Liang WY; Lin TC; Chen WS; Jiang JK; Yang SH; Chang SC; Lin JK
    Dis Colon Rectum; 2005 Jun; 48(6):1182-92. PubMed ID: 15793641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of total lymph node number in patients with T1-4N0M0 colorectal cancer.
    Berberoglu U
    Hepatogastroenterology; 2004; 51(60):1689-93. PubMed ID: 15532806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predictive of survival in patients with node-positive colorectal cancer in Taiwan.
    Wang WS; Chen PM; Chiou TJ; Liu JH; Fan FS; Lin TC; Jiang JK; Yang SH; Yen CC; Wang HS; Lin JK
    Hepatogastroenterology; 2000; 47(36):1590-4. PubMed ID: 11149009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.
    Zlobec I; Baker K; Minoo P; Jass JR; Terracciano L; Lugli A
    Clin Cancer Res; 2008 Jan; 14(1):143-8. PubMed ID: 18172264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of venous invasion by Elastica van Gieson stain and tumor budding predicts local and distant metastases in patients with T1 stage colorectal cancer.
    Suzuki A; Togashi K; Nokubi M; Koinuma K; Miyakura Y; Horie H; Lefor AT; Yasuda Y
    Am J Surg Pathol; 2009 Nov; 33(11):1601-7. PubMed ID: 19574884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated tumor cells in lymph nodes are not a prognostic marker for patients with stage I and stage II colorectal cancer.
    Lee MR; Hong CW; Yoon SN; Lim SB; Park KJ; Lee MJ; Kim WH; Park JG
    J Surg Oncol; 2006 Jan; 93(1):13-8; discussion 18-9. PubMed ID: 16353185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of pathological risk factors for lymph node metastasis in colorectal cancer.
    Fang W; Fan B; Xiong B
    Hepatogastroenterology; 2009; 56(91-92):663-6. PubMed ID: 19621676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rule of lymph node metastasis in colorectal cancer and its affecting factors].
    Tu SL; Ye ZY; Deng GL; Zhao ZS; Dong QJ; Zheng BA; Ding LP; Cao HF
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 May; 10(3):257-60. PubMed ID: 17520386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
    Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
    J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for occult lymph node metastasis of colorectal cancer invading the submucosa and indications for endoscopic mucosal resection.
    Yasuda K; Inomata M; Shiromizu A; Shiraishi N; Higashi H; Kitano S
    Dis Colon Rectum; 2007 Sep; 50(9):1370-6. PubMed ID: 17661146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mismatch repair system and p53 expression in patients with T1 and T2 colorectal cancer: predictive role of lymph node metastasis and survival.
    Huh JW; Kim HC; Kim SH; Park YA; Cho YB; Yun SH; Lee WY; Chun HK
    J Surg Oncol; 2014 Jun; 109(8):848-52. PubMed ID: 24623275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multivariate regression analysis of recurrence following curative surgery for colorectal cancer].
    Liang JL; Wan DS; Pan ZZ; Zhou ZW; Chen G; Li LR; Lu ZH; Wu XJ
    Ai Zheng; 2004 May; 23(5):564-7. PubMed ID: 15142455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor budding is predictive of lymphatic involvement and lymph node metastases in submucosal invasive colorectal adenocarcinomas and in non-polypoid compared with polypoid growths.
    Ogawa T; Yoshida T; Tsuruta T; Tokuyama W; Adachi S; Kikuchi M; Mikami T; Saigenji K; Okayasu I
    Scand J Gastroenterol; 2009; 44(5):605-14. PubMed ID: 19221929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the preoperative levels of CEA in patients with colorectal cancer.
    Marchena J; Acosta MA; Garcia-Anguiano F; Simpson H; Cruz F
    Hepatogastroenterology; 2003; 50(52):1017-20. PubMed ID: 12845969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 117.